Skip to content Skip to footer

Top 20 R&D Spending Biopharma Companies of 2025  

Shots:  Research and Development (R&D) serves as the driving force behind groundbreaking therapeutic innovations, laying the foundation for advancements that transform patient health and overall well-being  The global Top 20 pharmaceutical leaders spent ~$180B in 2024, with Merck & Co. contributing the most with a whopping $17.93B, followed by Johnson & Johnson ($17.23B) and Roche…

Read more

BioCardia Collaborates with CART-Tech to Advance Heart3D Fusion Imaging for Interventional Cardiology

Shots: BioCardia has entered into an exclusive development & commercialization agreement with CART-Tech for Heart3D Fusion Imaging to improve 2D x-ray images used for cardiac biotherapeutic delivery & biopsy procedures As per the deal, BioCardia secured global exclusive rights to CART-Tech’s IP for biotherapeutic interventions, plus exclusive US distribution rights for cardiac biopsy & global…

Read more

ThoughtSpot_Carla Adams9

Tips for Nurses on Enhancing Patient Care and Efficiency in Healthcare Settings

Imagine stepping into a world where compassion meets efficiency, where every action and word can make a profound difference in someone's life. This is the world of nursing, where healthcare professionals are not just caregivers but are pivotal in enhancing the patient experience and operational efficiency in healthcare settings.   In the bustling corridors of hospitals…

Read more

Disease of the Month - Ulcerative Colitis

Disease of the Month – Ulcerative Colitis

Shots:  To keep our readers acquainted with several disease conditions, ongoing trials, and available treatment options, PharmaShots brings every month a detailed take on a particular disease after thorough research   Continuing the series for the disease of the month, PharmaShots presents a condensed report on Ulcerative Colitis, which causes inflammation and sores (ulcers) in the digestive…

Read more

VIEWPOINTS_Nathan McCutcheon_2023

Nathan McCutcheon shares highlights of Qpex Biopharma’s acquisition by Shionogi

Shots:  Nathan McCutcheon, President, and Chief Executive Officer of Shionogi, shares the highlights of the recent acquisition of Qpex Biopharma by Shionogi   Nathan believes that Qpex’s specialized expertise and extensive experience in chemistry and molecular design are sure to strengthen and be useful for the combined antibiotic pipeline   The acquisition provides Shionogi exclusive development, manufacturing,…

Read more

Webinar Recap Beyond the Horizon Exploring Competitive Insights in the Life Science and Pharma Sectors

Webinar Recap: Beyond the Horizon: Exploring Competitive Insights in the Life Science and Pharma Sectors

Intuitive, informative, and gripping, could be an articulate three-word summarization of our recent webinar on Competitive Intelligence. October 5th, 2023, the day PharmaShots, in association with Octavus Consulting, organized a webinar dedicated to competitive intelligence and navigated the nuances that go beyond the conventional definition of CI. Titled "Beyond the Horizon: Exploring Competitive Insights in…

Read more

thoughtspot_Adrian Wallace

4 Steps To Ensure Clinical Trial Compliance

When performing research studies, clinical trial compliance plays a vital part in ensuring the safety and effectiveness of the research. It means adhering to ethical and regulatory requirements established by governing bodies that guarantee the well-being of study participants and the legitimacy of study results. Sponsors, investigators, and study sites could face considerable legal and…

Read more

Exclusive_Iris Loew-Friedrich_2023

Iris Loew-Friedrich, CMO and Head of Development Solutions at UCB Shares her Thoughts on the Launch of New Innovators Campaign

Shots: Iris shared the specifics of the launch of the UCB’s Innovators campaign. The campaign spotlights the R&D employees’ perspectives on innovation and aims to highlight why innovation is a key driving force at UCB for bettering the lives of patients She gave her thoughts on how UCB is adopting innovative AI programs that use…

Read more